Meridian Bioscience has appointed John Rice as an independent director. Rice joins Meridian from CincyTech, a firm that provides advice and capital to entrepreneurs and helps research institutions commercialize technology through startups. He has served as the director of life sciences since 2014. Rice is also the founder and, since 2003, managing partner of Triathlon Medical Ventures Partners, a venture capital firm that invests equity capital in early- and expansion-stage life science companies.
MDxHealth has appointed Paul Marr to the post of executive VP of sales for North America. Marr previously served as VP of sales, North America for Beckman Coulter, and also has worked for Hologic, Gen-Probe, Leica Biosystems, Bayer Diagnostics, and Siemens Healthcare. He joins MDxHealth, which is based in Belgium, in conjunction with the firm's expansion of its US sales force to 50 representatives.
Dovetail Genomics has appointed Ramesh Ramakrishnan as senior vice president of research and development. Before joining Dovetail, Ramakrishnan was executive vice president of R&D at Fluidigm, where he managed the development of single-cell genomic and proteomic tools, as well as bulk genomic analysis. Prior to Fluidigm, Ramakrishnan worked at Nanosphere and Motorola Life Sciences in assay and array development.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.